Walk into any supplement store or scroll through Amazon long enough and you will find creatine in more forms than you might expect. Creatine monohydrate. Creatine HCL. Creatine ethyl ester. Buffered creatine. Micronized creatine. Each one marketed with slightly different language — better absorption, less bloating, higher potency, no loading required.
For a woman in perimenopause trying to make an informed decision about what she puts in her body every day, the noise is exhausting. So here is a straightforward breakdown of what the science actually supports — and why the form of creatine you choose matters more than most product labels suggest.
The Research Reality
This is the most important fact in this entire discussion: approximately 95% of all creatine research has been conducted on creatine monohydrate.
That is not a small distinction. It represents decades of studies — thousands of trials across different populations, age groups, health conditions, and goals. The benefits attributed to creatine in the scientific literature — muscle strength and retention, cognitive energy support, bone health, training performance — were established using creatine monohydrate. The long-term safety profile that makes creatine one of the most trusted supplements in existence was built on creatine monohydrate.
When you read that creatine supports muscle retention in women during perimenopause, that finding comes from monohydrate research. When you read that creatine supports brain energy metabolism and may help with cognitive clarity, that finding comes from monohydrate research. When you read that creatine has an excellent long-term safety record, that safety record belongs to monohydrate.
Alternative forms like creatine HCL and creatine ethyl ester represent a small fraction of the available research. That means two things: we do not fully understand their benefits, and we do not fully understand their long-term side effects. For a supplement you are planning to take every day for months and years, that is a meaningful gap.
What Is Creatine HCL?
Creatine HCL — hydrochloride — is creatine bound to hydrochloric acid. Manufacturers claim this binding makes it more soluble in water and more easily absorbed by the body, theoretically allowing a lower dose to produce the same effect as a higher dose of monohydrate.
The marketing appeal is clear: smaller dose, less water retention, better absorption. For women who have had negative experiences with plain creatine powders — bloating, stomach discomfort, the gritty texture of older formulations — creatine HCL sounds like an upgrade.
The problem is that the research does not yet support those claims at the level monohydrate research does. There are studies on creatine HCL, but they are limited in number, shorter in duration, and conducted in smaller populations. We do not have the same depth of evidence on what creatine HCL does over two years of daily use, in women specifically, across different health conditions.
The CONCRET-MENOPA randomized controlled trial examined creatine HCL and creatine ethyl ester supplementation specifically in perimenopausal and menopausal women — measuring cognitive outcomes, clinical results, and actual brain creatine levels. This is some of the most targeted research available on alternative creatine forms in this exact population. The findings underscore why monohydrate remains the reference standard: it is the form with the established evidence base, and alternative forms cannot yet claim equivalence.
What Is Creatine Ethyl Ester?
Creatine ethyl ester is creatine with an ester group attached, marketed as having superior absorption compared to monohydrate. The claims are similar to HCL — smaller doses needed, better bioavailability, less water retention.
The research tells a different story. Studies that have directly compared creatine ethyl ester to monohydrate have generally found that monohydrate performs as well or better — and that ethyl ester may actually break down into creatinine (a waste product) in the digestive system before it can be absorbed, reducing its effectiveness.
This is not a minor formulation difference. It is a fundamentally different compound that behaves differently in the body — and not necessarily in the way the marketing suggests.
The Dose Problem
Beyond the form question, there is a second issue that affects many creatine products regardless of which form they use: the dose.
The clinical research on creatine — the studies that established its benefits for muscle, bone, and brain — used 3 to 5 grams of creatine monohydrate daily. That is the dose at which phosphocreatine stores are meaningfully replenished. That is the dose at which the results in the research were produced.
Many supplements — particularly blended products, protein powders, and pre-workouts that include creatine as one of many ingredients — list creatine on the label at 1 to 2 grams per serving. Some list it without disclosing the amount at all, hiding it inside a proprietary blend.
A dose below 3 grams is unlikely to produce the same benefits documented in research. The phosphocreatine system requires adequate daily replenishment to maintain elevated stores. An underdosed product may satisfy the marketing requirement of including creatine on the label without delivering any meaningful physiological effect.
This is why the dose matters as much as the form. 5 grams of creatine monohydrate daily is the research standard. Anything less — regardless of which form is used — is a departure from the evidence.
Gabi, a Creatine+ customer, described her previous experience with a different creatine product this way: "I almost gave up on creatine altogether after the last brand I tried made me feel like a water balloon. This one's different somehow. The energy thing is real though. I used to need a coffee around 3pm just to function and that's mostly gone now. No bloating so far, which honestly surprised me more than anything else."
That experience — creatine that causes bloating and water retention — is often the result of underdosed or poorly formulated products, or simply inconsistent use. The ingredient works. The formulation and the dose determine whether the experience does.
Why Monohydrate Wins — Simply Put
The case for creatine monohydrate is not complicated.
It is the most studied form of creatine by a significant margin. The benefits attributed to creatine supplementation — in muscle, bone, brain, and energy — were established using monohydrate. The long-term safety profile that makes creatine appropriate for daily use over months and years was built on monohydrate research.
Alternative forms may prove to be equally effective or safe with more research. But right now, for a woman making a daily decision about what she puts in her body, the evidence base for monohydrate is simply in a different category. Choosing an alternative form is choosing to be an early adopter of something the science has not yet fully characterized — both in terms of benefits and in terms of long-term side effects.
For daily supplementation, that is not a trade worth making.
What to Look for on a Label
When evaluating any creatine product, these are the questions worth asking:
| Question | What to Look For |
|---|---|
| What form of creatine is it? | Creatine monohydrate |
| What is the dose per serving? | 3-5 grams minimum — 5g is the research standard |
| Is the dose disclosed? | Full label transparency — no proprietary blends |
| Is it third-party tested? | NSF, Informed Sport, or cGMP manufacturing |
| What else is in it? | Check for fillers, artificial ingredients, or undisclosed blends |
ByEla Creatine+ and the Monohydrate Standard
ByEla Creatine+ is built around 5 grams of creatine monohydrate per serving — the full clinical dose, in the form with the most robust research base. No alternative forms. No proprietary blends. The dose is on the label because there is nothing to hide.
The formula was developed under European Union pharmaceutical standards and is manufactured at a cGMP-certified, FDA-compliant facility in the United States. Every batch is third-party tested for purity and potency.
For women in perimenopause and menopause who want the benefits the research actually supports — not the benefits that marketing claims — the choice of form and dose is not a minor detail. It is the foundation everything else is built on.
If you found this post useful, these may also be relevant:
- Creatine for Women Over 40 — What the Research Actually Says
- What Is ByEla Creatine+ and Is It Right for You?
- How Long Does It Take to Feel a Difference with Creatine for Women?
The research this post draws from:
- Smith-Ryan et al. — Creatine Supplementation in Women's Health: A Lifespan Perspective. Full review:
https://pmc.ncbi.nlm.nih.gov/articles/PMC7998865/ - The CONCRET-MENOPA randomized controlled trial examining the effects of creatine HCL and creatine ethyl ester supplementation on cognition, clinical outcomes, and brain creatine levels in perimenopausal and menopausal women. Full study:
https://pmc.ncbi.nlm.nih.gov/articles/PMC10487398/
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before beginning any new supplement regimen.